Education
About Us
Working with TipRanks
Follow Us
Thomas Heineman Insider Profile
4 Followers
Thomas Heineman, Divisional Head at Oncolytics Biotech, holds 148.10K shares in Oncolytics Biotech (Ticker: ONCY). Most recently, Thomas Heineman Bought $15,000 shares of Oncolytics Biotech on Jul 19, 2025 for an estimated value of 19.05K.
Thomas Heineman Oncolytics Biotech (ONCY)Divisional Head
Oncolytics Biotech (ONCY)
Divisional Head
Ranked #30,534 out of 102,596 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+58.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Thomas Heineman's holdings
Insider Roles
Divisional Head
Roles that Thomas Heineman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 15, 2022 - Jun 15, 2023
Return:+116.60%
The most profitable trade made by Thomas Heineman
Thomas Heineman's Trading History
List of latest transactions for each holding click on a transaction to see Thomas Heineman's performance on stock
You May Also Like
Thomas Heineman insider profile FAQ
What is the percentage of profitable transactions made by Thomas Heineman?
The percentage of profitable transactions made by Thomas Heineman is 50%.
What is the average return per transaction made by Thomas Heineman?
The average return per transaction made by Thomas Heineman is 58.30%.
What stocks does Thomas Heineman hold?
Thomas Heineman holds: ONCY stocks.
What was Thomas Heineman’s latest transaction?
Thomas Heineman latest transaction was an Informative Buy of $19.05K.
What was Thomas Heineman's most profitable transaction?
Thomas Heineman’s most profitable transaction was an Informative Buy of ONCY stock on June 15, 2022. The return on the trade was 116.60%.
What is Thomas Heineman's role in Oncolytics Biotech?
Thomas Heineman's role in Oncolytics Biotech is Divisional Head.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.